Elevance Health (ELV) revenue and earnings history
Elevance Health reported revenue of $199B for fiscal 2025 (year ended Dec 31, 2025), +12.5% on the year before, and net income of $5.66B.
Over 18 years, from fiscal 2007 to fiscal 2025, revenue grew at a compound rate of +6.8% a year.
Revenue and net income, 18 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $199B+12.5% | $7.2B | $5.66B | $4.29B | $1.12B | $3.17B | $276M | $2.6B | $1.53B | $9.49B | $31.9B | 10-K |
| 2024 |
The latest quarter, insider trades and fund moves: Elevance Health (ELV) on OQRO.
Common questions
What was Elevance Health's revenue in fiscal 2025?
$199B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 6, 2026. That is +12.5% on fiscal 2024 ($177B).
How fast has Elevance Health's revenue grown?
From $61.2B in fiscal 2007 to $199B in fiscal 2025: a compound annual growth rate of +6.8% over 18 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Elevance Health tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
